Private Equity
Location
Rotterdam, The Netherlands
Boston, MA, USA
Private Equity
All Portfolio items
See full Private Equity portfolio
Viroclinics Biosciences is a leader in diagnostic and clinical-trial services. It is one of the few labs in the world able to perform highly complex, specialized diagnostic and preclinical studies in the field of virology. Viroclinics operates globally as the preferred virology testing laboratory for top-ten biopharmaceutical companies.
Gilde acquired a majority share in 2013. During Gilde ownership Viroclinics developed new services for the biopharmaceutical industry, expanded its facilities and tripled its revenues. Viroclinics was sold in 2017 to Parcom Capital.
More Viroclinics Biosciences news
d3 Medicine LLC and Viroclinics Biosciences BV form virology drug development alliance to serve the
Gilde Healthcare Services acquires majority share in Viroclinics Biosciences from Erasmus MC
Private Equity
Eetgemak
Eetgemak is a leading producer and supplier of chilled meals, meal components, and dietary meals to the healthcare industry. The company supplies key institutions such as care homes, hospitals, schools and caterers, amongst others. Eetgemak delivers freshly prepared, healthier, and
Private Equity
Stepp Footcare
Stepp Footcare is an integrated footcare provider specializing in podiatry and orthopedic services for patients across the Netherlands. The group provides light-touch care to complex footcare solutions through podiatry, orthopedics, and multidisciplinary treatments. The business adopts a unique approach known
Private Equity
Artinis & NIRx
Artinis and NIRx are two leading developers of fNIRS systems. Both companies sell their systems to universities and other institutions across the globe. NIRx is headquartered in Berlin (DE), with a local sales office in Orlando, Florida (US) and Artinis
